Tobias S, Tu A, Shapiro AM, Mérette SAM, Lysyshyn M, Wood E, Buxton JA, Ti L Fentanyl concentrations in unregulated opioids and the blood of drug toxicity decedents AJE Adv, 2025. Link

Bird J, Tobias S, Grant C, Lysyshyn M, Tupper K, Wood E, Kerr T, Ti L Sharing drug checking results in a Canadian setting: a multi-site analysis Int J Drug Policy, 2025. PubMed

Esopenko H, Marshall BDL, Lysyshyn M, Grant C, Sherman SG, Wood E, Kerr T, Ti L Impact of having a regular drug dealer on obtaining drug checking results consistent with expectations during a drug toxicity crisis in a Canadian setting Drug Alcohol Depend, 2025. PubMed

Jackson E, Bach P, Socías ME, Brooks OM, Fairbairn N, Rodrigues M, Rosic T, Naji L, Jinks-Chang S, Nolan S, Chesney A, Reshetukha T, Samaan Z, Dennis B Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: findings from a prospective cohort study from 2013 to 2020 Drug Alcohol Depend, 2025. PubMed

Crepeault H, Cowan N, Socías ME, Riazi N, Knill A, Khela A, Wood E, Ti L Applying a modified version of the Prediction of Alcohol Withdrawal Severity Scale in a Canadian community withdrawal management setting Drug Alcohol Rev, 2025. PubMed

Morgan J, Taylor T, Nolan S, Blais A, Cywink SL, Duguay JM, Gibbons TA, Maxwell S, Marsh S, Pratt M, Glegg S Capacity building and creating supportive environments for inclusive community-based participatory research: a case study of the Overdose Prevention Peer Research Assistant (OPPRA) project Int J Qual Methods, 2025. Link

Mayer S, Fairbairn N, Fowler A, Boyd J, Kerr T, McNeil R Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada Harm Reduct J, 2025. PubMed

Karamouzian M, Cui Z, Hayashi K, DeBeck K, Reddon H, Buxton J, Kerr T Longitudinal polysubstance use patterns and non-fatal overdose: a repeated measures latent class analysis Int J Drug Policy, 2025. PubMed

Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME Comparative effectiveness of buprenorphine/naloxone and methadone on methamphetamine/amphetamine use among people with opioid use disorder in Canada Subst Use Addctn J, 2025. PubMed

Zazoulina J, Nolan S, Fairbairn N, Ryan A, Dennis BB, Bach P Intravenous fentanyl for symptom management in hospitalized patients with refractory opioid withdrawal: a retrospective cohort study J Addict Med, 2025. PubMed